Antilipolytic effects of growth hormone.
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D000242:Cyclic AMP / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D003864:Depression, Chemical; D004336:Drug Antagonism; D004837:Epinephrine / Q000037:antagonists & inhibitors*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005947:Glucose / Q000378:metabolism; D005990:Glycerol / Q000096:biosynthesis; D013006:Growth Hormone / Q000494:pharmacology* / Q000502:physiology; D000960:Hypolipidemic Agents / Q000494:pharmacology; D066298:In Vitro Techniques; D008053:Lipid Mobilization / Q000187:drug effects*; D008297:Male; D051381:Rats
D005230:Fatty Acids, Nonesterified; D000960:Hypolipidemic Agents; D003609:Dactinomycin; D013006:Growth Hormone; D000242:Cyclic AMP; D005947:Glucose; D005990:Glycerol; D004837:Epinephrine